RWM
ABBV icon

Rialto Wealth Management’s AbbVie ABBV Stock Holding History

Rialto Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$259K Buy
1,189
+62
+6% +$13.8K 0.06% 136
2025
Q4 		$257K Sell
1,127
-12
-1% -$2.73K 0.06% 140
2025
Q3 		$264K Buy
1,139
+20
+2% +$4.07K 0.07% 134
2025
Q2 		$208K Buy
1,119
+15
+1% +$2.79K 0.06% 148
2025
Q1 		$231K Buy
1,104
+17
+2% +$3.31K 0.07% 138
2024
Q4 		$193K Buy
+1,087
New +$200K 0.06% 150

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Rialto Wealth Management's ABBV Position: Q1 2026 in Review

Rialto Wealth Management increased its AbbVie (ABBV) stake by 5.5% in Q1 2026, buying an estimated $13.8K and bringing the position to 1,189 shares worth $259K. The position accounts for 0.06% of the portfolio, ranked #136.

Rialto Wealth Management first reported a position in ABBV in Q4 2024 and has held it in 6 quarters since. The position peaked at $264K in Q3 2025. 4,075 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Rialto Wealth Management held 1,189 shares of AbbVie worth $259K as of Q1 2026.
  • Rialto Wealth Management bought 62 AbbVie shares in Q1 2026, an estimated $13.8K.
  • AbbVie made up 0.06% of Rialto Wealth Management's portfolio in Q1 2026, its #136 holding.
  • Rialto Wealth Management first reported a position in AbbVie in Q4 2024 and has held it in 6 quarters since.
  • Rialto Wealth Management's AbbVie position peaked at $264K in Q3 2025.
  • 4,075 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Rialto Wealth Management's 13F filing for Q1 2026, filed 14 May 2026.